🇯🇵 日本語 🇺🇸 English
3,791 companies 2,409 AI summaries 1,867 risk analyses 1,334 growth scores Register free — watchlist & alerts →
EDINET 7979 Positive Risk Analyzed 📈 Growth 7/10

SHOFU INC.

Annual Securities Report - 154th Term(2025/04/01 - 2026/03/31) ／ 2026-06-23 11:36

Covers EDINET statutory filings (TDNET timely disclosures / earnings flashes are not included).

EarningsNew ProductNew MarketCapacityVolume
AI Summary 2026-06-23 11:41

FY2025 (ending March 2026) achieved revenue +3.3%, operating profit -3.1%, but net profit +13.2% to record-high, driven by higher non-operating income and gains on investment securities. Company unveiled long-term Vision10 targeting global dental top 10 by 2040 with sales goal of ¥250B and 20% op margin.

KEY POINTS
  • Record high results: Revenue ¥3,999M (+3.3%), operating profit ¥5,226M (-3.1%), net profit ¥4,887M (+13.2%) driven by investment gains and forex benefits
  • Vision10 long-term plan announced Dec 2025 targeting 2040 with revenue ¥2,500B and op profit ¥500B (20% margin); positioned as 'leading company in digital dentistry and oral care'
  • Manufacturing capacity expansion underway: new HQ factory first phase completed, subsidiaries initiated construction to support global demand; 5th Mid-Term Plan (FY2028 target: ¥50B revenue, ¥7.5B op profit) on track
📊 Revenue
Revenue +3.3% (¥3,870M → ¥3,999M)
💰 Operating profit
Operating profit -3.1% (¥5,391M → ¥5,226M)
🔮 Outlook
FY2026 outlook: Revenue +7.4%, OP +14.9%, NP -2.7% (Not stated in disclosure)
📈 Growth outlook 📈 Growth 7/10
Stable growth expected through CAD/CAM, preventive care and orthodontics expansion in dental segment, accelerated overseas deployment, and new manufacturing investments. Currently in investment phase toward Vision10 2040 targets.
Growth drivers
  • Expansion of digital dentistry (CAD/CAM products) sales domestically and internationally
  • Business expansion into growth fields including preventive care, orthodontics, and sleep dentistry
  • Manufacturing capacity increase to meet global demand and improve margins
  • New product launches (Even Force orthodontic springs, Shabrio elderly training device) driving market expansion
Risk and growth scores and tags are AI-generated estimates from analyzing the disclosure. They are not guarantees of fact, nor investment advice or recommendations. Make investment decisions at your own discretion.
⚠️ Extracted Risk Factors
CategoryDescriptionScoreNew
Cybersecurity Risk External cyber attacks, insider threats, and confidential data breaches could disrupt operations and damage reputation. Despite security measures, potential adverse impact on business continuity and financial results. 7/10
Natural Disaster Risk Large-scale natural disasters and climate extremes (earthquakes, typhoons, floods) could halt operations at domestic and international facilities, disrupting supply and harming revenue and profitability. 7/10
Regulatory Risk Business subject to multiple regulations (Pharma-Medical Device Law, environmental, foreign exchange). Non-compliance or loss of manufacturing/sales license could severely impair operations. 7/10
International Business Risk High overseas revenue exposure vulnerable to geopolitical tensions, forex volatility, policy changes, and healthcare system reforms. FY2025 saw impact from Middle East tensions in Europe. 6/10
Competitive Intensity Risk Global competition intensifying with new entrants; margin pressure and share loss risk. Nail business already pressured by low-cost competitors and EU regulatory tightening on raw materials. 6/10
Product Quality & Safety Risk As dental device maker, product defects or safety incidents trigger product liability suits and recalls, causing significant costs and reputational damage. Quality systems critical. 6/10
Human Capital Risk Difficulty securing and developing specialized talent needed for global expansion amid Japan's declining workforce. Critical for Vision10 implementation. 5/10
M&A & Investment Risk Planned M&A and capex expansion risk incomplete due diligence or integration challenges, impacting ROI and balance sheet. FY2025 saw ¥3.4B capex outflow. 5/10
7/10 Cybersecurity Risk
External cyber attacks, insider threats, and confidential data breaches could disrupt operations and damage reputation. Despite security measures, potential adverse impact on business continuity and financial results.
7/10 Natural Disaster Risk
Large-scale natural disasters and climate extremes (earthquakes, typhoons, floods) could halt operations at domestic and international facilities, disrupting supply and harming revenue and profitability.
7/10 Regulatory Risk
Business subject to multiple regulations (Pharma-Medical Device Law, environmental, foreign exchange). Non-compliance or loss of manufacturing/sales license could severely impair operations.
6/10 International Business Risk
High overseas revenue exposure vulnerable to geopolitical tensions, forex volatility, policy changes, and healthcare system reforms. FY2025 saw impact from Middle East tensions in Europe.
6/10 Competitive Intensity Risk
Global competition intensifying with new entrants; margin pressure and share loss risk. Nail business already pressured by low-cost competitors and EU regulatory tightening on raw materials.
6/10 Product Quality & Safety Risk
As dental device maker, product defects or safety incidents trigger product liability suits and recalls, causing significant costs and reputational damage. Quality systems critical.
5/10 Human Capital Risk
Difficulty securing and developing specialized talent needed for global expansion amid Japan's declining workforce. Critical for Vision10 implementation.
5/10 M&A & Investment Risk
Planned M&A and capex expansion risk incomplete due diligence or integration challenges, impacting ROI and balance sheet. FY2025 saw ¥3.4B capex outflow.
X LinkedIn Threads Bluesky Facebook
Track Japanese disclosures with JSIGNAL

AI summaries, risk & growth analysis, watchlist alerts and a screener for every Japanese listed company.

Start free — 30-day trial Login